Else Nutrn (OTCMKTS:BABYF – Get Free Report) and GlucoTrack (NASDAQ:GCTK – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.
Profitability
This table compares Else Nutrn and GlucoTrack’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Else Nutrn | -180.47% | -843.88% | -168.42% |
| GlucoTrack | N/A | N/A | -352.05% |
Valuation & Earnings
This table compares Else Nutrn and GlucoTrack”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Else Nutrn | $5.82 million | 5.14 | -$11.08 million | ($0.11) | -0.73 |
| GlucoTrack | N/A | N/A | -$22.60 million | ($1,119.80) | -0.01 |
Else Nutrn has higher revenue and earnings than GlucoTrack. Else Nutrn is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
10.9% of GlucoTrack shares are owned by institutional investors. 0.7% of GlucoTrack shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for Else Nutrn and GlucoTrack, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Else Nutrn | 0 | 0 | 0 | 0 | 0.00 |
| GlucoTrack | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
Else Nutrn has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, GlucoTrack has a beta of 0.24, indicating that its stock price is 76% less volatile than the S&P 500.
Summary
GlucoTrack beats Else Nutrn on 6 of the 11 factors compared between the two stocks.
About Else Nutrn
Else Nutrition Holdings Inc. focuses on the research, development, manufacturing, marketing, and sale of plant-based food and nutrition products for infants, toddlers, children's, and adults in North America, Israel, Australia, and New Zealand. It offers baby and toddler snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby and toddler nutrition formula products; kids and adult nutrition products; and complementary food products for babies, as well as toddler drink for toddlers ages 12-36 months; and follow-on formula for infants. The company provides its products through online. Else Nutrition Holdings Inc. was founded in 2012 and is headquartered in Tel Aviv, Israel.
About GlucoTrack
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Receive News & Ratings for Else Nutrn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Else Nutrn and related companies with MarketBeat.com's FREE daily email newsletter.
